Nucleic Acids Research, 1983, Vol. 11, No. 9 2779-2800
© 1983
ENZYMOLOGY |
Biochemical characterization of topoisomerase I purified from avian erythrocytes
Department of Microbiology, The Ohio State University Columbus, OH 43210, USA
Received October 19, 1982. Revised February 24, 1983. Accepted February 24, 1983.
A type I topoisomerase has been purified from avian erythrocyte nuclei. The most pure fraction contains one major polypeptide of Mr = 105,000 (80% of total) and several minor ones of lower molecular weight. Active forms of the topoisomerase were identified by covalently binding the enzyme to P-DNA, digesting with nuclease and detecting 32-p labeled peptides by sodium dodecyl sulfate polyaorylamide gel electrophoresis. Topoisomerase activity, as measured by the ability to oovalently bind DMA, is associated with the following peptides: Mr = 105, 83, 54 and 30,000. The similar chromatographic properties of the various forms of topoisomerase suggests a common structural Identity as previously proposed for the HeLa topoisomerase I (Liu, L.F. and Miller, K.G. (1981) Proc. Nat 1. Acad. Soi. USA 78, 34873191). The avian enzyme is similar to other eucaryotic type I DNA topoisomerases in that it covalently binds double and single stranded DNA forming an enzyme linked to the 3'-phosphoryl end and after binding to single stranded DNA it can transfer the single stranded donor DNA to an acceptor DNA possessing 5'-OH end groups. The binding site size of topoisomerase on DNA has also been determined using micrococoal nuclease to digest unprotected DNA in the native enzyme/DNA complex. The enzyme blocks access to the helix over a span of 25 bp. These findings are discussed in light of the distribution and function of topoisomerase I in chromatin.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. Gomez-Manzano, M. M. Alonso, W.K. A. Yung, F. McCormick, D. T. Curiel, F. F. Lang, H. Jiang, B. N. Bekele, X. Zhou, R. Alemany, et al. Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan Clin. Cancer Res., January 15, 2006; 12(2): 556 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Kampranis, A. D. Bates, and A. Maxwell A model for the mechanism of strand passage by DNA gyrase PNAS, July 20, 1999; 96(15): 8414 - 8419. [Abstract] [Full Text] [PDF] |
||||

